首页/数据集/Outcomes based on time to molnupiravir commencement from symptom onset.

Outcomes based on time to molnupiravir commencement from symptom onset.

Figshare2023-03-14 更新2026-04-28 收录

数据链接：

https://figshare.com/articles/dataset/Outcomes_based_on_time_to_molnupiravir_commencement_from_symptom_onset_/22271306 数据链接链接失效反馈

官方服务：

资源简介：

Outcomes based on time to molnupiravir commencement from symptom onset.

应用场景：

创建时间：

2023-03-14

病毒药物疗效

免疫应答监测

Data are median (interquartile range). Before and after denote before and after treatment, respectively. *P<0.05, ¶P<0.01, versus before treatment for the same parameter (Wilcoxon signed-ranks test).

NIAID Data Ecosystem60

Mini data set of children enrolled on protease inhibitor treatment as Essos Hospital Centre.

儿童HIV治疗

病毒药物疗效

ART: antiretroviral therapy, NNRTI: non-nucleoside reverse transcriptase inhibitor; PI/r: ritonavir boosted protease inhibitor;. (XLS)

NIAID Data Ecosystem50

All data in women in Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand

乙肝母婴阻断

病毒药物疗效

All data in women Study Description A Phase 3, randomized clinical trial to assess the efficacy and safety of tenofovir disoproxil fumarate (TDF) in hepatitis B virus (HBV) infected, s and e antigen p

NIAID Data Ecosystem40

Measures of the impact of NAI treatment under various conditions * .

病毒药物疗效

流感治疗评估

Measures of the impact of NAI treatment under various conditions *.

NIAID Data Ecosystem60

Changes in anti-IAV-specific IgG production in untreated patients and patients treated with OSV and ZNV for 5 days, with or without CAM.

流感免疫反应建模

病毒药物疗效

NIAID Data Ecosystem40